Editorials

Colorectal cancer screening for older adults

BMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h2029 (Published 16 April 2015) Cite this as: BMJ 2015;350:h2029
  1. Hermann Brenner, professor of epidemiology
  1. 1German Cancer Consortium, German Cancer Research Center, INF 280, 69120 Heidelberg, Germany
  1. h.brenner{at}dkfz.de

Benefits take time to accrue, with implications for upper age limits

In recent years evidence that the incidence of and mortality from colorectal cancer can be substantially reduced by screening has been accumulating. Strong evidence from randomised trials is available for both fecal occult blood testing1 2 3 and screening with flexible sigmoidoscopy.4 5 6 7 8 Observational epidemiological studies suggest an even larger benefit associated with screening colonoscopy.8 9 10 11 Screening for colorectal cancer is now widely recommended by expert committees and is being introduced in a rapidly increasing number of countries.

However, many unanswered questions remain about the practical details of screening for colorectal cancer, and empirical evidence to guide screening programmes is sparse. In a linked paper (doi:10.1136/bmj.h1662), Tang and colleagues ask a particularly important question about screening older adults using flexible sigmoidoscopy; specifically at what age screening would no longer be appropriate.12 Using a survival meta-analysis of flexible sigmoidoscopy trials,12 the authors estimated the time it would take for screening to achieve defined reductions in mortality from colorectal cancer and deduced that screening …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe